Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FFIV✓SelectedUSD · FFIVGSK vs FFIV performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs FFIV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.3%
FFIV return
+95.4%
Excess return
-30.1%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioFFIVExcessAlpha
1D+0.5%-2.7%+3.2%+0.5%
7D+1.1%-0.5%+1.7%+1.1%
30D+6.3%-32.4%+38.7%+6.1%
3M+1.8%-25.7%+27.5%+1.9%
6M+1.7%-13.5%+15.2%+1.9%
YTD+6.5%+21.1%-14.6%+6.3%
1Y+9.5%+29.4%-19.9%+9.0%
3Y+65.3%+94.9%-29.6%+57.4%
All+65.3%+95.4%-30.1%+57.4%

Cumulative growth

Daily Returns

Daily percentage return beside FFIV.

Daily Out/Under-Performance

Portfolio return minus FFIV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FFIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded FFIV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling